Ngā hua rapu - Gail J. Roboz
- E whakaatu ana i te 1 - 20 hua o te 90
- Haere ki te Whārangi Whai Ake
-
1
Novel Approaches to the Treatment of Acute Myeloid Leukemia mā Gail J. Roboz
I whakaputaina 2011Revisão -
2
Acute myeloid leukemia stem cells: seek and destroy mā Gail J. Roboz, Mónica L. Guzmán
I whakaputaina 2009Revisão -
3
Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis mā Gail J. Roboz, Sérgio Dias, George Lam, William J. Lane, Steven L. Soignet, Raymond P. Warrell, Shahin Rafii
I whakaputaina 2000Artigo -
4
The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types mā Hermann Einsele, Hossein Borghaei, Robert Z. Orlowski, Marion Subklewe, Gail J. Roboz, Gerhard Zugmaier, Peter Kufer, Karim Iskander, Hagop M. Kantarjian
I whakaputaina 2020Revisão -
5
Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide mā Gail J. Roboz, Ellen K. Ritchie, Rebecca F. Carlin, Michael S. Samuel, Leanne Gale, Juliette L. Provenzano-Gober, Tania J. Curcio, Eric J. Feldman, Paul Kligfield
I whakaputaina 2014Artigo -
6
-
7
The effect of initial molecular profile on response to recombinant interferon‐α (rIFNα) treatment in early myelofibrosis mā Richard T. Silver, Ariella Barel, Elena Lascu, Ellen K. Ritchie, Gail J. Roboz, Paul J. Christos, Attilio Orazi, Duane C. Hassane, Wayne Tam, Nicholas C.P. Cross
I whakaputaina 2017Artigo -
8
TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia mā Aaron D. Goldberg, Chetasi Talati, Pinkal Desai, Christopher Famulare, Sean M. Devlin, Noushin Farnoud, David A. Sallman, Jeffrey E. Lancet, Gail J. Roboz, Kendra Sweet, Martin S. Tallman
I whakaputaina 2018Artigo -
9
A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response mā Keith W. Pratz, Jorge E. Cortés, Gail J. Roboz, Niranjan Rao, Omotayo Arowojolu, Adam Stine, Yukimasa Shiotsu, Aiko Shudo, Shiro Akinaga, Donald Small, Judith E. Karp, Mark J. Levis
I whakaputaina 2008Artigo -
10
In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche mā Hong Zong, Siddhartha Sen, Guodong Zhang, Mu Chuanjie, Z F Albayati, David G. Gorenstein, Yang Liu, M. Ferrari, Peter A. Crooks, Gail J. Roboz, Haifa Shen, Mónica L. Guzmán
I whakaputaina 2015Carta -
11
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels mā Vicenta Trujillo-Alonso, Edwin C. Pratt, Hongliang Zong, Andres Lara-Martinez, Charalambos Kaittanis, Mohamed O. Rabie, Valerie A. Longo, Michael W. Becker, Gail J. Roboz, Jan Grimm, Mónica L. Guzmán
I whakaputaina 2019Artigo -
12
A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond mā Tony Taldone, Tai Wang, Anna Rodina, Nagavarakishore Pillarsetty, Chander Singh Digwal, Sahil Sharma, Pengrong Yan, Suhasini Joshi, Piyusha P. Pagare, Alexander Bolaender, Gail J. Roboz, Mónica L. Guzmán, Gabriela Chiosis
I whakaputaina 2019Revisão -
13
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations mā Nuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, Fatima Bhopalwala Ali, Bas J. Wouters, Sang Min Lee, Ellen K. Ritchie, Pinkal Desai, Mónica L. Guzmán, Gail J. Roboz, Duane C. Hassane
I whakaputaina 2017Artigo -
14
Somatic mutations precede acute myeloid leukemia years before diagnosis mā Pinkal Desai, Nuria Mencia-Trinchant, Oleksandr Savenkov, Michael S. Simon, Gloria Cheang, Sang‐Min Lee, Michael Samuel, Ellen K. Ritchie, Mónica L. Guzmán, Karla V. Ballman, Gail J. Roboz, Duane C. Hassane
I whakaputaina 2018Artigo -
15
First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leuk... mā Eric J. Feldman, Jeffrey E. Lancet, Jonathan E. Kolitz, Ellen K. Ritchie, Gail J. Roboz, Alan F. List, Steven L. Allen, Ekatherine Asatiani, Lawrence D. Mayer, Christine E. Swenson, Arthur C. Louie
I whakaputaina 2011Artigo -
16
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m <i>IDH1</i> ) acute myeloid leukemia (AML) mā Jorge E. Cortés, Brian A. Jonas, Gary J. Schiller, Alice S. Mims, Gail J. Roboz, Andrew H. Wei, Pau Montesinos, P. Brent Ferrell, Karen Yee, Pierre Fenaux, Anthony P. Schwarer, Justin M. Watts
I whakaputaina 2024Artigo -
17
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML mā Joseph M. Scandura, Gail J. Roboz, Michelle Moh, Ewelina Morawa, Fabienne Brenet, Jahar R Bose, Luis Juárez Villegas, Usama Gergis, Sebastian Mayer, Cindy Ippoliti, Tania J. Curcio, Ellen K. Ritchie, Eric J. Feldman
I whakaputaina 2011Artigo -
18
Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia mā Gail J. Roboz, Ellen K. Ritchie, Yulia Dault, Linda Lam, Danielle C. Marshall, Nicole M. Cruz, Hsiao-Ting Hsu, Duane C. Hassane, Paul J. Christos, Cindy Ippoliti, Joseph M. Scandura, Mónica L. Guzmán
I whakaputaina 2018Artigo -
19
Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia mā Mónica L. Guzmán, Neng Yang, Krishan K. Sharma, Marlene Balys, Cheryl A. Corbett, Craig T. Jordan, Michael W. Becker, Ulrich Steidl, Omar Abdel‐Wahab, Ross L. Levine, Guido Marcucci, Gail J. Roboz, Duane C. Hassane
I whakaputaina 2014Artigo -
20
Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia mā Mayumi Sugita, Román Galetto, Hongliang Zong, Nathan Ewing-Crystal, Vicenta Trujillo-Alonso, Nuria Mencia-Trinchant, Winnie Yip, Stéphanie Filipe, Céline Lebuhotel, Agnès Gouble, Duane C. Hassane, Julianne Smith, Gail J. Roboz, Mónica L. Guzmán
I whakaputaina 2022Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Oncology
Gene
Myeloid leukemia
Biology
Biochemistry
Leukemia
Gastroenterology
Bone marrow
DNA methylation
Gene expression
Chemotherapy
Myelodysplastic syndromes
Chemistry
Genetics
Adverse effect
Azacitidine
Astrobiology
Refractory (planetary science)
Cancer research
Surgery
Decitabine
Physics
Immunology
Clinical trial
Myeloid
Hypomethylating agent
International Prognostic Scoring System
Pharmacology